The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma

The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma

Background: Magnesium sulphate, administered by the intravenous (i.v.) or inhaled (nebulised) route, has been proposed as a treatment for adults with acute severe asthma. Existing trials show mixed results and uncertain evidence of...

Full description

Bibliographic Details
Main Authors: Steve Goodacre, Judith Cohen, Mike Bradburn, John Stevens, Alasdair Gray, Jonathan Benger, Tim Coats, on behalf of the 3Mg Research Team
Format: Article
Language:English
Published: NIHR Journals Library 2014-04-01
Series:Health Technology Assessment
Subjects:
acute severe asthma
magnesium sulphate
randomised controlled trial
3mg
nebulised
intravenous
placebo
Online Access:https://doi.org/10.3310/hta18220

Internet

https://doi.org/10.3310/hta18220

Similar Items